Search Results 871-880 of 20514 for hepatitis

  1. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

    hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible ... positive for hepatitis C (HCV) antibody are eligible only if polymerase chain reaction

  2. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? Katie Helwig. May 4, 2023. Leading scientists share advances in Omics- ...

  3. A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination with Crizotinib - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) or seropositive test for hepatitis C virus or hepatitis B virus. Participating Mayo Clinic locations.

  4. Medical Research & Education - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Joel Streed. October 1, 2021. First · Previous ... 114 · 115 · 116 · 117 · 118 · 119 · 120 ... Next ...

  5. Mayo Clinic Transplant Center - Doctors

    langitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Acute liver failure ...

  6. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? Katie Helwig. May 4, 2023. Leading scientists share advances in Omics- ...

  7. Stacey A. Rizza, M.D. - Mayo Clinic Faculty Profiles

    Her clinical practice is focused on HIV and transplant infectious diseases, while her research work investigates how HIV and hepatitis C virus cause liver ...

  8. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    ... hepatitis B surface antigen [antiHBs]) must be screened using real-time polymerase chain reaction (PCR) measurement of hepatitis B virus (HBV) DNA levels.

  9. Efficacy And Safety Of Vedolizumab Subcutaneous (SC) As Maintenance Therapy In Crohn's Disease - Mayo Clinic

    HBV immune participants (ie, being hepatitis B surface antigen [HBsAg] negative and hepatitis B antibody positive) may, however, be included. History of any ...

  10. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Clinically active Hepatitis B defined as positive HBsAg; or positive HBcAb with detectable hepatitis B virus (HBV) DNA viral load. Patients who are HBcAb ...